Immunogenicity of glycine nanoparticles containing a chimeric antigen as Brucella vaccine candidate

PURPOSE: Brucellosis as a worldwide zoonotic illness affect domestic animals and humans doesn't have any vaccine for the prevention of infection in humans yet. The aim of this study was to evaluate the specific immune response following the administration of glycine nanoparticles as adjuvant an...

Descripción completa

Detalles Bibliográficos
Autores principales: Karevan, Ghazal, Ahmadi, Kazem, Taheri, Ramezan Ali, Fasihi-Ramandi, Mahdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892938/
https://www.ncbi.nlm.nih.gov/pubmed/33628752
http://dx.doi.org/10.7774/cevr.2021.10.1.35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892938/
https://www.ncbi.nlm.nih.gov/pubmed/33628752
http://dx.doi.org/10.7774/cevr.2021.10.1.35

Ejemplares similares